prikaz prve stranice dokumenta Soluble adhesion molecules in patients with acute coronary syndrome after percutaneous coronary intervention with drug-coated balloon, drug-eluting stent or bare metal stent
Pristup korisnicima matične ustanove
Znanstveni rad - Izvorni znanstveni rad
Soluble adhesion molecules in patients with acute coronary syndrome after percutaneous coronary intervention with drug-coated balloon, drug-eluting stent or bare metal stent
Medical hypotheses, 95 (2016); 20-23. https://doi.org/10.1016/j.mehy.2016.08.008
Tomulić, Vjekoslav; Gobić, David; Lulić, Davorka; Židan, David; Zaputović, Luka

Institucijski repozitorij: Repozitorij Medicinskog fakulteta u Rijeci

Citirajte ovaj rad

Tomulić, V., Gobić, D., Lulić, D., Židan, D. i Zaputović, L. (2016). Soluble adhesion molecules in patients with acute coronary syndrome after percutaneous coronary intervention with drug-coated balloon, drug-eluting stent or bare metal stent. Medical hypotheses, 95., 20-23. doi: 10.1016/j.mehy.2016.08.008

Tomulić, Vjekoslav, et al. "Soluble adhesion molecules in patients with acute coronary syndrome after percutaneous coronary intervention with drug-coated balloon, drug-eluting stent or bare metal stent." Medical hypotheses, vol. 95, 2016, str. 20-23. https://doi.org/10.1016/j.mehy.2016.08.008

Tomulić, Vjekoslav, David Gobić, Davorka Lulić, David Židan i Luka Zaputović. "Soluble adhesion molecules in patients with acute coronary syndrome after percutaneous coronary intervention with drug-coated balloon, drug-eluting stent or bare metal stent." Medical hypotheses 95 (2016): 20-23. https://doi.org/10.1016/j.mehy.2016.08.008

Tomulić, V., et al. (2016) 'Soluble adhesion molecules in patients with acute coronary syndrome after percutaneous coronary intervention with drug-coated balloon, drug-eluting stent or bare metal stent', Medical hypotheses, 95, str. 20-23. doi: 10.1016/j.mehy.2016.08.008

Tomulić V, Gobić D, Lulić D, Židan D, Zaputović L. Soluble adhesion molecules in patients with acute coronary syndrome after percutaneous coronary intervention with drug-coated balloon, drug-eluting stent or bare metal stent. Medical hypotheses [Internet]. 2016. [pristupljeno 18.05.2024.];95:20-23. doi: 10.1016/j.mehy.2016.08.008

V. Tomulić, D. Gobić, D. Lulić, D. Židan i L. Zaputović, "Soluble adhesion molecules in patients with acute coronary syndrome after percutaneous coronary intervention with drug-coated balloon, drug-eluting stent or bare metal stent", Medical hypotheses, vol. 95, str. 20-23, 2016. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:564182. [Citirano: 18.05.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:564182
Podaci o radu
Naslov (engleski)Soluble adhesion molecules in patients with acute coronary syndrome after percutaneous coronary intervention with drug-coated balloon, drug-eluting stent or bare metal stent
AutorVjekoslav Tomulić
AutorDavid Gobić
AutorDavorka Lulić
AutorDavid Židan
AutorLuka Zaputović
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za internu medicinu)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
Adhesion molecules play an important role in inflammation, atherosclerosis and coronary artery disease (CAD). These molecules are expressed on the surface of dysfunctional endothelial cells, causing inflammatory cells from the circulation to adhere and migrate through the endothelium. Their expression is upregulated in acute coronary syndrome (ACS) and after percutaneous coronary intervention (PCI). The contact between stent struts and endothelium upregulates endothelial cell gene expression, endothelial cell activation and inflammation. The paclitaxel or sirolimus eluting stents inhibited expression of adhesion molecules in several studies and reduced the incidence of major adverse cardiac events (MACE) after drug-eluting stent (DES) over bare metal stent (BMS) implantation. Therefore, we propose that elevated serum levels of the soluble adhesion molecules after primary PCI in patients treated with BMS or DES implantation versus drug-coated balloon (DCB) application to the vulnerable coronary plaque might be a predictor of MACE and further adverse outcomes. Consequently, DCB-only strategy in patients with ACS might be a superior approach in comparison to BMS implantation and non-inferior approach when compared to DES implantation.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaMedical hypotheses
Brojčani podacivol. 95, str. 20-23
p-ISSN0306-9877
DOIhttps://doi.org/10.1016/j.mehy.2016.08.008
URN:NBNurn:nbn:hr:184:564182
Datum objave publikacije2016
URL dokumentahttp://bib.irb.hr/888445
Vrsta resursaTekst
Prava pristupaInstitucijski pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2022-03-09 12:55:00